Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Disease Browser
Parent Node:
expand
Adrenal Insufficiency (D000309)
Parent Node:
expand
Hereditary Central Nervous System Demyelinating Diseases (D020279)
Parent Node:
expand
Mental Retardation, X-Linked (D038901)
Parent Node:
expand
Peroxisomal Disorders (D018901)
..Starting node
..expand
Adrenoleukodystrophy (D000326)

       Child Nodes:
........expandMelanodermic leukodystrophy (C538676)
........expandPeroxisomal ACYL-COA oxidase deficiency (C536662)
........expandPEROXISOME BIOGENESIS DISORDER 2B (OMIM:202370)
........expandWells Jankovic syndrome (C536692)



 Sister Nodes: 
..expandAcatalasia (D020642)
..expandAdrenoleukodystrophy (D000326) Child4
..expandBile acid synthesis defect, congenital, 4 (C535444)
..expandChondrodysplasia Punctata, Rhizomelic (D018902) Child3
..expandMevalonate Kinase Deficiency (D054078)
..expandPeroxisome Biogenesis Disorder, Complementation Group 1 (C566568)
..expandPeroxisome Biogenesis Disorder, Complementation Group 11 (C566634)
..expandPeroxisome Biogenesis Disorder, Complementation Group 12 (C566405)
..expandPeroxisome Biogenesis Disorder, Complementation Group 13 (C566625)
..expandPeroxisome Biogenesis Disorder, Complementation Group 14 (C563964)
..expandPeroxisome Biogenesis Disorder, Complementation Group 3 (C566633)
..expandPeroxisome Biogenesis Disorder, Complementation Group 4 (C563301)
..expandPeroxisome Biogenesis Disorder, Complementation Group 7 (C566422)
..expandPeroxisome Biogenesis Disorder, Complementation Group 9 (C566387)
..expandPeroxisome Biogenesis Disorder, Complementation Group D (C566388)
..expandPeroxisome Biogenesis Disorder, Complementation Group E (C566569)
..expandPeroxisome Biogenesis Disorder, Complementation Group G (C566406)
..expandPeroxisome Biogenesis Disorder, Complementation Group H (C566626)
..expandPeroxisome Biogenesis Disorder, Complementation Group J (C563965)
..expandPeroxisome Biogenesis Disorder, Complementation Group K (C566624)
..expandPeroxisome Biogenesis Disorder, Complementation Group R (C566635)
..expandPeroxisome biogenesis disorders (C536664)
..expandRefsum Disease (D012035) Child4
..expandRefsum Disease, Infantile (D052919)
..expandZellweger Syndrome (D015211) Child3
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM, CTD
Term ID:335
Name:Adrenoleukodystrophy
Definition:An X-linked recessive disorder characterized by the accumulation of saturated very long chain fatty acids in the LYSOSOMES of ADRENAL CORTEX and the white matter of CENTRAL NERVOUS SYSTEM. This disease occurs almost exclusively in the males. Clinical features include the childhood onset of ATAXIA; NEUROBEHAVIORAL MANIFESTATIONS; HYPERPIGMENTATION; ADRENAL INSUFFICIENCY; SEIZURES; MUSCLE SPASTICITY; and DEMENTIA. The slowly progressive adult form is called adrenomyeloneuropathy. The defective gene ABCD1 is located at Xq28, and encodes the adrenoleukodystrophy protein (ATP-BINDING CASSETTE TRANSPORTERS).
Alternative IDs:OMIM:300100
ParentIDs:MESH:D000309|MESH:D018901|MESH:D020279|MESH:D038901
TreeNumbers:C10.228.140.163.100.362.250 |C10.228.140.163.100.680.100 |C10.228.140.695.625.250 |C10.314.400.250 |C10.597.606.643.455.124 |C16.320.322.500.124 |C16.320.400.525.124 |C16.320.565.189.362.250 |C16.320.565.189.680.100 |C16.320.565.663.112 |C18.452.132.100.362.250 |C1
Synonyms:ADDISON DISEASE AND CEREBRAL SCLEROSIS |Adrenoleukodystrophy, X-Linked |Adrenomyeloneuropathy |ALD |ALD (Adrenoleukodystrophy) |AMN, INCLUDED |BRONZE SCHILDER DISEASE |MELANODERMIC LEUKODYSTROPHY ADRENOMYELONEUROPATHY, INCLUDED |Schilder Addison Complex |Schilder
Slim Mappings:Endocrine system disease|Genetic disease (inborn)|Metabolic disease|Nervous system disease
Reference: MedGen: D000326
MeSH: D000326
OMIM: 300100;

Genes: ABCD1;
Phenotypes
1 HP:0001417X-linked inheritance
2 HP:0001419X-linked recessive inheritance
3 HP:0002500Abnormal cerebral white matter morphology
4 HP:0000924Abnormality of the skeletal system
5 HP:0007018Attention deficit hyperactivity disorder
6 HP:0000618Blindness
7 HP:0002607Bowel incontinence
8 HP:0001283Bulbar palsy
9 HP:0000726Dementia
10 HP:0003455Elevated circulating long chain fatty acid concentration
11 HP:0000365Hearing impairment
12 HP:0000953Hyperpigmentation of the skin
13 HP:0000135Hypogonadism
14 HP:0000802Impotence
15 HP:0002311Incoordination
16 HP:0002070Limb ataxia
17 HP:0002371Loss of speech
18 HP:0002180Neurodegeneration
19 HP:0002385Paraparesis
20 HP:0001271Polyneuropathy
21 HP:0008207Primary adrenal insufficiency
22 HP:0003676Progressive
23 HP:0000709Psychosis
24 HP:0001250Seizure
25 HP:0001350Slurred speech
26 HP:0001258Spastic paraplegia
27 HP:0002078Truncal ataxia
28 HP:0002839Urinary bladder sphincter dysfunction
29 HP:0000020Urinary incontinence
30 HP:0000572Visual loss
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_000033.3(ABCD1):c.-18_8del26 (p.Met1_Gly66del)215ABCD1Pathogenic387906497RCV000012069; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152990704152990729NM_000033.3:c.-18_8del26NP_000024.2:p.Met1_Gly66delNC_000023.10:g.152990704_152990729del26OMIM Allelic Variant:300371.0026C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.31_46del16 (p.Arg11Serfs)215ABCD1Pathogenic398123109RCV000077962; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152990752152990767NM_000033.3:c.31_46del16NP_000024.2:p.Arg11SerfsNC_000023.10:g.152990752_152990767del16-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.253dupC (p.Arg85Profs)215ABCD1Pathogenic713993050RCV000149556; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152990974152990974NM_000033.3:c.253dupCNP_000024.2:p.Arg85ProfsNC_000023.10:g.152990974dupC-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.346G>A (p.Gly116Arg)215ABCD1Pathogenic398123110RCV000077963; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152991067152991067NM_000033.3:c.346G>ANP_000024.2:p.Gly116ArgNC_000023.10:g.152991067G>AHGMD:CM960028C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.406C>T (p.Gln136Ter)215ABCD1Pathogenic398123111RCV000077964; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152991127152991127NM_000033.3:c.406C>TNP_000024.2:p.Gln136TerNC_000023.10:g.152991127C>T-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.421G>A (p.Ala141Thr)215ABCD1Pathogenic193922097RCV000029289; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152991142152991142NM_000033.3:c.421G>ANP_000024.2:p.Ala141ThrNC_000023.10:g.152991142G>AHGMD:CM950030C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.443A>G (p.Asn148Ser)215ABCD1Pathogenic128624216RCV000012049; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152991164152991164NM_000033.3:c.443A>GNP_000024.2:p.Asn148SerNC_000023.10:g.152991164A>GOMIM Allelic Variant:300371.0006C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.498_520del23 (p.Val167Leufs)215ABCD1Pathogenic398123112RCV000077966; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152991219152991241NM_000033.3:c.498_520del23NP_000024.2:p.Val167LeufsNC_000023.10:g.152991219_152991241del23-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.520T>G (p.Tyr174Asp)215ABCD1Pathogenic128624217RCV000012050; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152991241152991241NM_000033.3:c.520T>GNP_000024.2:p.Tyr174AspNC_000023.10:g.152991241T>GOMIM Allelic Variant:300371.0007C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.614C>A (p.Ala205Glu)215ABCD1Likely pathogenic398123113RCV000077967; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152991335152991335NM_000033.3:c.614C>ANP_000024.2:p.Ala205GluNC_000023.10:g.152991335C>AHGMD:CM105367C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.651G>C (p.Lys217Asn)215ABCD1Likely pathogenic864309520RCV000202647; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152991372152991372NM_000033.3:c.651G>CNP_000024.2:p.Lys217AsnNC_000023.10:g.152991372G>C-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.796G>A (p.Gly266Arg)215ABCD1Pathogenic128624218RCV000012051; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152991517152991517NM_000033.3:c.796G>ANP_000024.2:p.Gly266ArgNC_000023.10:g.152991517G>AOMIM Allelic Variant:300371.0008C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.838C>T (p.Arg280Cys)215ABCD1Likely pathogenic193922098RCV000029290; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152991559152991559NM_000033.3:c.838C>TNP_000024.2:p.Arg280CysNC_000023.10:g.152991559C>T-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.871G>A (p.Glu291Lys)215ABCD1Pathogenic128624213RCV000012044; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152991592152991592NM_000033.3:c.871G>ANP_000024.2:p.Glu291LysNC_000023.10:g.152991592G>AOMIM Allelic Variant:300371.0001C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.871_873delGAG (p.Glu292del)215ABCD1Pathogenic387906496RCV000012066; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152991592152991594NM_000033.3:c.871_873delGAGNP_000024.2:p.Glu292delNC_000023.10:g.152991592_152991594delGAGOMIM Allelic Variant:300371.0023C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.886T>C (p.Tyr296His)215ABCD1Likely pathogenic797044611RCV000173053; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152991607152991607NM_000033.3:c.886T>CNP_000024.2:p.Tyr296HisNC_000023.10:g.152991607T>C-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.887A>G (p.Tyr296Cys)215ABCD1Pathogenic797044610RCV000173051; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X152991608152991608NM_000033.3:c.887A>GNP_000024.2:p.Tyr296CysNC_000023.10:g.152991608A>G-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1165C>G (p.Arg389Gly)215ABCD1Pathogenic128624215RCV000012048; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153001649153001649NM_000033.3:c.1165C>GNP_000024.2:p.Arg389GlyNC_000023.10:g.153001649C>GOMIM Allelic Variant:300371.0005C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1201C>G (p.Arg401Gly)215ABCD1Likely pathogenic727503786RCV000152719; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153001685153001685NM_000033.3:c.1201C>GNP_000024.2:p.Arg401GlyNC_000023.10:g.153001685C>GHGMD:CM122938C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1202G>A (p.Arg401Gln)215ABCD1Pathogenic128624219RCV000012052; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153001686153001686NM_000033.3:c.1202G>ANP_000024.2:p.Arg401GlnNC_000023.10:g.153001686G>AOMIM Allelic Variant:300371.0009C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1252C>T (p.Arg418Trp)215ABCD1Pathogenic128624220RCV000012053; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153001826153001826NM_000033.3:c.1252C>TNP_000024.2:p.Arg418TrpNC_000023.10:g.153001826C>TOMIM Allelic Variant:300371.0010C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1288C>T (p.Gln430Ter)215ABCD1Pathogenic797044726RCV000178024; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153001862153001862NM_000033.3:c.1288C>TNP_000024.2:p.Gln430TerNC_000023.10:g.153001862C>T-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1366dupC (p.Arg456Profs)215ABCD1Likely pathogenic193922093RCV000029284; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153001940153001940NM_000033.3:c.1366dupCNP_000024.2:p.Arg456ProfsNC_000023.10:g.153001940dupC-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1390C>T (p.Arg464Ter)215ABCD1Pathogenic128624221RCV000012054; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153001964153001964NM_000033.3:c.1390C>TNP_000024.2:p.Arg464TerNC_000023.10:g.153001964C>TOMIM Allelic Variant:300371.0011C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1396C>T (p.Gln466Ter)215ABCD1Pathogenic398123100RCV000077950; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153002613153002613NM_000033.3:c.1396C>TNP_000024.2:p.Gln466TerNC_000023.10:g.153002613C>THGMD:CM950048C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1415_1416delAG (p.Gln472Argfs)215ABCD1Pathogenic387906494RCV000012055; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153002632153002633NM_000033.3:c.1415_1416delAGNP_000024.2:p.Gln472ArgfsNC_000023.10:g.153002632_153002633delAGHGMD:CD941566,OMIM Allelic Variant:300371.0012C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1429G>T (p.Glu477Ter)215ABCD1Pathogenic128624222RCV000012056; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153002646153002646NM_000033.3:c.1429G>TNP_000024.2:p.Glu477TerNC_000023.10:g.153002646G>TOMIM Allelic Variant:300371.0013C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1451C>G (p.Pro484Arg)215ABCD1Pathogenic128624214RCV000012045; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153002668153002668NM_000033.3:c.1451C>GNP_000024.2:p.Pro484ArgNC_000023.10:g.153002668C>GOMIM Allelic Variant:300371.0002C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1544C>T (p.Ser515Phe)215ABCD1Pathogenic128624223RCV000012057; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153005601153005601NM_000033.3:c.1544C>TNP_000024.2:p.Ser515PheNC_000023.10:g.153005601C>TOMIM Allelic Variant:300371.0014C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1552delC (p.Arg518Glyfs)215ABCD1Pathogenic387906495RCV000012058; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153005609153005609NM_000033.3:c.1552delCNP_000024.2:p.Arg518GlyfsNC_000023.10:g.153005609delCOMIM Allelic Variant:300371.0015C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1552C>T (p.Arg518Trp)215ABCD1Pathogenic128624224RCV000012059; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153005609153005609NM_000033.3:c.1552C>TNP_000024.2:p.Arg518TrpNC_000023.10:g.153005609C>THGMD:CM940037,OMIM Allelic Variant:300371.0016C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1553G>A (p.Arg518Gln)215ABCD1Pathogenic398123102RCV000077955; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153005610153005610NM_000033.3:c.1553G>ANP_000024.2:p.Arg518GlnNC_000023.10:g.153005610G>AHGMD:CM940036C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1586G>A (p.Gly529Asp)215ABCD1Likely pathogenic398123103RCV000077956; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153005643153005643NM_000033.3:c.1586G>ANP_000024.2:p.Gly529AspNC_000023.10:g.153005643G>AHGMD:CM107839C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1592T>C (p.Leu531Pro)215ABCD1Likely pathogenic193922094RCV000029285; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153005649153005649NM_000033.3:c.1592T>CNP_000024.2:p.Leu531ProNC_000023.10:g.153005649T>C-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1660C>A (p.Arg554Ser)215ABCD1Likely pathogenic398123104RCV000077957; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153006053153006053NM_000033.3:c.1660C>ANP_000024.2:p.Arg554SerNC_000023.10:g.153006053C>A-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1661G>A (p.Arg554His)215ABCD1Pathogenic201568579RCV000152720; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153006054153006054NM_000033.3:c.1661G>ANP_000024.2:p.Arg554HisNC_000023.10:g.153006054G>AHGMD:CM000643C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1679C>T (p.Pro560Leu)215ABCD1Pathogenic398123105RCV000077958; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153006072153006072NM_000033.3:c.1679C>TNP_000024.2:p.Pro560LeuNC_000023.10:g.153006072C>THGMD:CM950052C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1771C>T (p.Arg591Trp)215ABCD1Pathogenic398123106RCV000077959; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153006164153006164NM_000033.3:c.1771C>TNP_000024.2:p.Arg591TrpNC_000023.10:g.153006164C>THGMD:CM993108C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1780+4G>A215ABCD1Uncertain significance193922095RCV000029286; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153006177153006177NM_000033.3:c.1780+4G>ANC_000023.10:g.153006177G>A-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1781-1G>A215ABCD1Pathogenic797044781RCV000180095; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153008440153008440NM_000033.3:c.1781-1G>ANC_000023.10:g.153008440G>A-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1802G>A (p.Trp601Ter)215ABCD1Pathogenic398123107RCV000077960; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153008462153008462NM_000033.3:c.1802G>ANP_000024.2:p.Trp601TerNC_000023.10:g.153008462G>AHGMD:CM983813C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1817C>T (p.Ser606Leu)215ABCD1Pathogenic128624225RCV000180094; RCV000012062; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002; MedGen:C1868690,OMIM:240200X153008477153008477NM_000033.3:c.1817C>TNP_000024.2:p.Ser606LeuNC_000023.10:g.153008477C>TOMIM Allelic Variant:300371.0019C1868690 240200 Addison's disease; C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1825G>A (p.Glu609Lys)215ABCD1Pathogenic150346282RCV000152721; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153008485153008485NM_000033.3:c.1825G>ANP_000024.2:p.Glu609LysNC_000023.10:g.153008485G>AHGMD:CM950056C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1849C>T (p.Arg617Cys)215ABCD1Pathogenic4010613RCV000012065; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153008509153008509NM_000033.3:c.1849C>TNP_000024.2:p.Arg617CysNC_000023.10:g.153008509C>TOMIM Allelic Variant:300371.0022C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1850G>A (p.Arg617His)215ABCD1Pathogenic11146842RCV000012064; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153008510153008510NM_000033.3:c.1850G>ANP_000024.2:p.Arg617HisNC_000023.10:g.153008510G>AHGMD:CM940040,OMIM Allelic Variant:300371.0021C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1866-10G>A215ABCD1Pathogenic398123108RCV000077961; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153008665153008665NM_000033.3:c.1866-10G>ANC_000023.10:g.153008665G>AHGMD:CS951342C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.1992-2A>G215ABCD1Pathogenic797044626RCV000173621; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153008941153008941NM_000033.3:c.1992-2A>GNC_000023.10:g.153008941A>G-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.2006_2007delAC (p.His669Leufs)215ABCD1Pathogenic797044625RCV000173620; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153008957153008958NM_000033.3:c.2006_2007delACNP_000024.2:p.His669LeufsNC_000023.10:g.153008957_153008958delAC-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.2190G>A (p.Pro730=)215ABCD1Likely benign193922096RCV000029287; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153009141153009141NM_000033.3:c.2190G>ANP_000024.2:p.Pro730=NC_000023.10:g.153009141G>A-C0162309 300100 Adrenoleukodystrophy
NM_000033.3(ABCD1):c.*208G>C215ABCD1Uncertain significance193922092RCV000029288; NMedGen:C0162309,OMIM:300100,ORPHA:43,SNOMED CT:65389002X153009397153009397NM_000033.3:c.*208G>CNC_000023.10:g.153009397G>C-C0162309 300100 Adrenoleukodystrophy